75 related articles for article (PubMed ID: 21693154)
1. Norepinephrine transporter (NET) knock-out upregulates dopamine and serotonin transporters in the mouse brain.
Solich J; Faron-Gorecka A; Kusmider M; Palach P; Gaska M; Dziedzicka-Wasylewska M
Neurochem Int; 2011 Aug; 59(2):185-91. PubMed ID: 21693154
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.
Gilsbach R; Faron-Górecka A; Rogóz Z; Brüss M; Caron MG; Dziedzicka-Wasylewska M; Bönisch H
J Neurochem; 2006 Feb; 96(4):1111-20. PubMed ID: 16417582
[TBL] [Abstract][Full Text] [Related]
3. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
4. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
5. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
[TBL] [Abstract][Full Text] [Related]
6. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
Haenisch B; Bönisch H
Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
Zhang S; Zhen J; Reith ME; Dutta AK
J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
[TBL] [Abstract][Full Text] [Related]
8. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
[TBL] [Abstract][Full Text] [Related]
9. Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters.
Olivier JD; Cools AR; Deen PM; Olivier B; Ellenbroek BA
Eur J Pharmacol; 2010 Mar; 629(1-3):7-11. PubMed ID: 20004658
[TBL] [Abstract][Full Text] [Related]
10. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
11. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the dopamine transporter by interaction with Secretory Carrier Membrane Protein 2.
Fjorback AW; Müller HK; Haase J; Raarup MK; Wiborg O
Biochem Biophys Res Commun; 2011 Mar; 406(2):165-70. PubMed ID: 21295544
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine transporter knock-out alters expression of the genes connected with antidepressant drugs action.
Solich J; Kolasa M; Kusmider M; Faron-Gorecka A; Pabian P; Zurawek D; Szafran-Pilch K; Dziedzicka-Wasylewska M
Brain Res; 2015 Jan; 1594():284-92. PubMed ID: 25451113
[TBL] [Abstract][Full Text] [Related]
14. Altered reward circuitry in the norepinephrine transporter knockout mouse.
Gallagher JJ; Zhang X; Hall FS; Uhl GR; Bearer EL; Jacobs RE
PLoS One; 2013; 8(3):e57597. PubMed ID: 23469209
[TBL] [Abstract][Full Text] [Related]
15. Life-long norepinephrine transporter (NET) knock-out leads to the increase in the NET mRNA in brain regions rich in norepinephrine terminals.
Solich J; Kolasa M; Kusmider M; Pabian P; Faron-Gorecka A; Zurawek D; Szafran-Pilch K; Kedracka-Krok S; Jankowska U; Swiderska B; Dziedzicka-Wasylewska M
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1099-108. PubMed ID: 26002194
[TBL] [Abstract][Full Text] [Related]
16. Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation.
Ikeda T; Kurosawa M; Uchikawa C; Kitayama S; Nukina N
Biochem Biophys Res Commun; 2005 Feb; 327(1):218-24. PubMed ID: 15629452
[TBL] [Abstract][Full Text] [Related]
17. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
18. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
Ase AR; Reader TA; Hen R; Descarries L
J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
[TBL] [Abstract][Full Text] [Related]
19. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
